SEC Filing Details

Luminex^® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

SEC Filing Details

Document Details

Form

Filing Date

Jul 17, 2020

Document Date

Jul 15, 2020

Form Description

Statement of changes in beneficial ownership of securities

Filing Group

3,4,5

Company

Luminex Corporation

Issuer

LUMINEX CORP

Filer

Collins Charles J.

Filing Formats